Sažetak
Uvod/Cilj. Nemelanomski karcinomi kože (engl. non-melanoma skin cancers – NMSC) su jedni od najbrže rastućih karcinoma širom sveta. Iako imaju relativno nisku stopu smrtnosti, zbog cene koja je potrebna za njihovo lečenje, predstavljaju veliku brigu u javnom zdravlju mnogih država. Ova studija imala je dva osnovna cilja: prvi, da analizira trend standardizovane incidencije NMCS u Srbiji i drugi, da se na osnovu anliziranog trenda proceni potreba za izradu nacionalne strategije za prevenciju i kontrolu ovog karcinoma. Metode. Iz Registra za rak Srbije izdvojeni su svi slučajeve NMCS registrovani u centralnoj Srbiji od 1. januara 1999 do 3. decembra 2015. godine. Trend kretanja i godišnji procenat promene incidencije (engl. annual percentage change –APC) izračunat je regresionom analizom pomoću tačke spajanja. Rezultati. NMCS su se značajno povećavali kod oba pola sa APC od +2,32% (p < 0,001). Značajno povećanje trenda incidencije je bilo veće kod žena (APC, +2.63%; p < 0,0001) nego kod muškaraca (APC, +2.01%; p < 0,001). Zaključak. Rezultati pokazuju kontinuirano povećanje stope incidencije NMCS u Srbiji. Bez nacionalne preventivne strategije vrlo je malo verovatno da će sadašnje sporadične preventivne aktivnosti smanjiti ovaj rastući trend.
Ključne reči
karcinom, bazocelularni;
karcinom, planocelularni;
incidenca;
srbija
Reference
Fahradyan A, Howell AC, Wolfswinkel EM, Tsuha M, Sheth P, Wong AK. Updates on the Management of Non-Melanoma Skin Cancer (NMSC). Healthcare (Basel) 2017; 5(4): pii: E82.
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality pat-terns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49(6): 1374‒403.
Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166(5): 1069‒80.
Adelson P, Sharplin GR, Roder DM, Eckert M. Keratinocyte cancers in South Australia: incidence, geographical variabil-ity and service trends. Aust N Z J Public Health 2018; 42(4): 329‒33.
Ahluwalia J, Hadjicharalambous E, Mehregan D. Basal cell carci-noma in skin of color. J Drugs Dermatol 2012; 11(4): 484‒6.
Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Inci-dence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Derma-tol 2015; 151(10): 1081‒6.
Yu SL, Lee SK. Ultraviolet radiation: DNA damage, repair, and human disorders. Molec Cell Toxicol 2017; 13(1): 21‒8.
Amaro-Ortiz A, Yan B, D'Orazio JA. Ultraviolet radiation, ag-ing and the skin: prevention of damage by topical cAMP manipulation. Molecules 2014; 19(5): 6202‒19.
Bauer A, Diepgen TL, Schmitt J. Is occupational solar ultravio-let irradiation a relevant risk factor for basal cell carcinoma? A systematic review and meta-analysis of the epidemiologi-cal literature. Br J Dermatol 2011; 165(3): 612‒25.
Schmitt J, Seidler A, Diepgen TL, Bauer A. Occupational ultra-violet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: a systematic review and meta-analysis. Br J Dermatol 2011; 164(2): 291‒307.
Wehner MR, Shive ML, Chren M-M, Han J, Qureshi AA, Linos E. Indoor tanning and non-melanoma skin cancer: system-atic review and meta-analysis. BMJ 2012; 345: e5909.
Qin J, Holman DM, Jones SE, Berkowitz Z, Guy GP Jr. State In-door Tanning Laws and Prevalence of Indoor Tanning Among US High School Students, 2009-2015. Am J Public Health 2018; 108(7): 951‒6.
Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124(6): 869-71.
Shih STF, Carter R, Heward S, Sinclair C. Skin cancer has a large impact on our public hospitals but prevention pro-grams continue to demonstrate strong economic creden-tials. Aust N Z J Public Health 2017; 41(4): 371‒6.
Mofidi A, Tompa E, Spencer J, Kalcevich C, Peters CE, Kim J, et al. The economic burden of occupational non-melanoma skin cancer due to solar radiation. J Occup Environ Hyg 2018; 15(6): 481‒91.
Housman TS, Feldman SR, Williford PM, Fleischer AB Jr, Gold-man ND, Acostamadiedo JM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare popula-tion. J Am Acad Dermatol 2003; 48(3): 425‒9.
Perera E. Public health strategies for preventing non mela-noma skin cancers . Global Dermatol 2014; 1(2): 36‒8.
Videnović G, Miljuš D, Ilić D, Krasić D, Živković S. Nonmela-noma Skin Cancer in the Population of the City of Bel-grade in the Period 1999-2011. Srp Arh Celok Lek 2015; 143(5‒6): 290‒5.
Braun RP, Ulrich K, Hunger R, Gaide O, Arnold A, Merat R, et al. Evaluation of the National Swiss Skin Cancer Screening Campaign 2013: Do We Do the Right Thing. Dermatolo-gy 2017; 233(5): 404‒9.
Stratigos AJ, Forsea AM, van der Leest RJ, De Vries E, Nagore E, Bulliard JL, et al. Euromelanoma: a dermatology-led Euro-pean campaign against nonmelanoma skin cancer and cu-taneous melanoma. Past, present and future. Br J Dermatol 2012; 167(Suppl 2): 99‒104.
Del Marmol V. The Euromelanoma campaign. Actas Der-mosifiliogr 2016; 107(5): 365. (English, Spanish)
Antonijevic A, Rancic N, Ilic M, Kocic B, Stevanovic J, Milic M. Trends in incidence of non-melanoma and melanoma skin cancers in central Serbia. Srp Arh Celok Lek. 2018; 146(7‒8): 391‒5.
World Health Organization. International Statistical Classifica-tion of Diseases. 10th revision (ICD-10). Geneva: World Health Organization; 2008.
Jensen OM, Parkin DM, Maclennan R, Muir CS, Skeet RG. Can-cer Registration: Principles and Methods. Lyon: Interna-tional Agency for Research on Cancer; 1991.
Sinclair R. Nonmelanoma skin cancer in Australia. Br J Dermatol 2013; 168: 1‒2.
Martín-García E, Arias-Santiago S, Serrano-Ortega S, Buendía-Eisman A. Changes in the Incidence of Skin and Lip Can-cer Between 1978 and 2007. Actas Dermosifiliogr 2017; 108(4): 335‒45. (Spanish)
Eisemann N, Waldmann A, Geller AC, Weinstock MA, Volkmer B, Greinert R. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol 2014; 134(1): 43‒50.
Deady S, Sharp L, Comber H. Increasing skin cancer inci-dence in young, affluent, urban populations: a challenge for prevention. Br J Dermatol 2014; 171(2): 324‒31.
Ceylan C, Oztürk G, Alper S. Non-melanoma skin cancers be-tween the years of 1990 and 1999 in Izmir, Turkey: demo-graphic and clinicopathological characteristics. J Dermatol 2003; 30(2): 123‒31.
Harrison SL, Garzón-Chavez DR, Nikles CJ. Sun protection policies of Australian primary schools in a region of high sun exposure. Health Educ Res 2016; 31(3): 416‒28.
Jones SB, Beckmann K, Rayner J. Australian primary schools’ sun protection policy and practice: evaluating the impact of the National SunSmart Schools Program. Health Promot J Austr 2008;19: 86‒90.
Miljković S, Baljozović D, Krajnović D, Tasić L, Sbutega-Milosević G. The impact of education on adolescents' sun behavior: experiences from Serbia. Srp Arh Celok Lek 2014; 142(5‒6): 330‒6.
Kim RH, Armstrong AW. Nonmelanoma skin cancer. Der-matol Clin 2012; 30 1): 125‒39, ix.
Leiter U, Keim U, Eigentler T, Katalinic A, Holleczek B, Martus P. Incidence, Mortality, and Trends of Nonmelanoma Skin Cancer in Germany. J Invest Dermatol 2017; 137(9): 1860‒7.
Lipozencić J, Celić D, Strnad M, Toncić RJ, Pasić A, Rados J. Skin cancers in Croatia, 2003-2005: epidemiological study. Coll Antropol 2010; 34(3): 865‒9.
Brougham ND, Dennett ER, Tan ST. Changing incidence of non-melanoma skin cancer in New Zealand. ANZ J Surg 2011; 81(9): 633‒6.
Demers AA, Nugent Z, Mihalcioiu C, Wiseman MC, Kliewer EV. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population. J Am Acad Dermatol 2005; 53(2): 320‒8.
Heidari M, Najafi F. Trends of skin cancer incidence in 6 geographical regions of the Islamic Republic of Iran, 2000-2005. East Mediterr Health J 2013; 19(1): 59‒65.
Zeb A, Rasool A, Nasreen S. Cancer incidence in the districts of Dir (North West Frontier Province), Pakistan: a prelim-inary study. J Chin Med Assoc 2008; 71(2): 62‒5.
Hollestein LM, De Vries E, Nijsten T. Trends of cutaneous squamous cell carcinoma in the Netherlands: increased in-cidence rates, but stable relative survival and mortality 1989-2008. Eur J Cancer 2012; 48(13): 2046‒53.
Birch-Johansen F, Jensen A, Mortensen L, Olesen AB, Kjaer SK. Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: rapid incidence increase among young Danish women. Int J Cancer 2010; 127(9): 2190‒8.
Boi S, Cristofolini M, Micciolo R, Polla E, Dalla Palma P. Epide-miology of skin tumours: data from the cutaneous cancer registry in Trentino, Italy. J Cutan Med Surg 2003; 7(4): 300‒5.
Levi F, Te VC, Randimbison L, Erler G, La Vecchia C. Trends in skin cancer incidence in Vaud: an update, 1976-1998. Eur J Cancer Prev 2001; 10(4): 371‒3.
Lee G, Ko NY, Son SW, Bae HJ, Ha JS, Pak HY, et al. The impact of ozone depletion on skin cancer incidence in Ko-rea. Br J Dermatol 2013; 169(5): 1164‒5.
De Vries E, van de Poll-Franse LV, Louwman WJ, de Gruijl FR, Coebergh JW. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol 2005; 152(3): 481‒8.
Pawlak MT, Bui M, Amir M, Burkhardt DL, Chen AK, Del-lavalle RP. Legislation restricting access to indoor tanning throughout the world. Arch Dermatol 2012; 148(9): 1006‒12.
Bataille V, Boniol M, De Vries E, Severi G, Brandberg Y, Sasieni P, et al. A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur J Cancer 2005; 41(14): 2141‒9.
Karagas MR, Stannard VA, Mott LA, Slattery MJ, Spencer SK, Weinstock MA. Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst 2002; 94(3): 224‒6.
Keim U, van der Pols JC, Williams GM, Green AC. Exclusive development of a single type of keratinocyte skin cancer: evidence from an Australian population-based cohort study. J Invest Dermatol 2015; 135(3): 728‒33.
Hoey SE, Devereux CE, Murray L, Catney D, Gavin A, Kumar S, et al. Skin cancer trends in Northern Ireland and conse-quences for provision of dermatology services. Br J Derma-tol 2007; 156(6): 1301‒7.
Stang A, Ziegler S, Büchner U, Ziegler B, Jöckel KH, Ziegler V. Malignan melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach. Int J Dermatol 2007; 46(6): 564‒70.